Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication in Pediatric Chronic ITP
NCT03172676Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Jan 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin and clarithromycin in Helicobacter pylori infection (3 arms), sponsored by Assiut University. Primary endpoint: Effects of Helicobacter pylori infection eradication on platelet counts at 6 months. Status: unknown.
02
Drugs
amoxicillinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03172676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172676.